| Symbol | Company | Weighting |
|---|---|---|
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 2.58% |
| EXAS | EXACT SCIENCES CORP | 2.38% |
| EYPT | EYEPOINT INC | 2.35% |
| FULC | FULCRUM THERAPEUTICS, INC. | 2.22% |
| TSHA | TAYSHA GENE THERAPIES I | 2.08% |
| KRRO | KORRO BIO | 2.03% |
| SPRY | ARS PHARMACEUTICALS | 2.00% |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.96% |
| AVTX | AVALO THERAPEUTICS INC | 1.93% |
| TNDM | TANDEM DIABETES CARE INC | 1.85% |
| RVMD | REVOLUTION MEDICINES INC | 1.80% |
| BMY | BRISTOL MYERS SQUIBB CO | 1.80% |
| NEO | NEOGENOMICS INC | 1.78% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.78% |
| EWTX | EDGEWISE THERAPEUTICS | 1.76% |
| IONS | IONIS PHARMACEUTICALS INC | 1.75% |
| ARQT | ARCUTIS BIOTHERAPEUTICS | 1.75% |
| BRKR | BRUKER CORP | 1.74% |
| AXSM | AXSOME THERAPEUTICS INC. | 1.71% |
| MRK | MERCK & CO. NEW | 1.70% |
| ICLR | ICON PLC | 1.70% |
| OCS | OCULIS HOLDING AG | 1.69% |
| XENE | XENON PHARMACEUTICALS | 1.69% |
| HUM | HUMANA INC | 1.68% |
| RGEN | REPLIGEN CORP | 1.66% |
| DYN | DYNE THERAPEUTICS, INC. | 1.65% |
| IDYA | IDEAYA BIOSCIENCES, INC | 1.63% |
| RVTY | REVVITY INC | 1.62% |
| MDT | MEDTRONIC PLC | 1.61% |
| ALC | ALCON INC | 1.61% |
| ZTS | ZOETIS INC | 1.60% |
| PRQR | PROQR THERAPEUTICS NV | 1.59% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.58% |
| AZN | ASTRAZENECA PLC-ADR | 1.58% |
| ELV | ELEVANCE HEALTH INC | 1.57% |
| ISRG | INTUITIVE SURGICAL INC | 1.57% |
| DHR | DANAHER CORP | 1.57% |
| TVTX | TRAVERE THERAPEUTICS INC | 1.57% |
| WAT | WATERS CORP | 1.56% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.56% |
| THC | TENET HEALTHCARE CORP | 1.55% |
| CDTX | CIDARA THERAPEUTICS INC | 1.54% |
| ALKS | ALKERMES INC | 1.53% |
| HCA | HCA HOLDINGS INC | 1.52% |
| ABT | ABBOTT LABORATORIES | 1.52% |
| UNH | UNITEDHEALTH GROUP INC | 1.51% |
| DNLI | DENALI THERAPEUTICS INC. | 1.51% |
| MCK | MCKESSON CORP | 1.50% |
| SLNO | SOLENO THERAPEUTICS INC | 1.50% |
| URGN | UROGEN PHARMA LTD. | 1.50% |
| PCVX | VAXCYTE INC | 1.48% |
| ABBV | ABBVIE INC | 1.47% |
| SYK | STRYKER CORP | 1.47% |
| LLY | ELI LILLY CORP | 1.45% |
| SNY | SANOFI- AVENTIS- ADR | 1.44% |
| BSX | BOSTON SCIENTIFIC | 1.43% |
| VCEL | VERICEL CORP | 1.42% |
| IRON | DISC MEDICINE INC | 1.38% |
| PODD | INSULET CORP | 1.34% |
| JANX | JANUX THERAPEUTICS INC | 0.74% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.